The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

Firms / L••••••••• S•••••••• P••• L•••

L••••••••• S•••••••• P••• L•••

Accelerator · probableS••••••••l•••••••••.comSEC exempt reporting adviserpart of L••••••••• V•••••••

One of 2 advisers that share l•••••••••.com; the firm is L••••••••• V•••••••. L••••••••• V•••••••. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

name or self-description says accelerator

Importance
11
low
Active deployment
0
low
Emerging
0
low
Completeness
63
high
Freshness
95
high
Research priority
3
low
Identity and regulatory footprint
Headquarters
S••••••••, S••••••••adviserinfo.sec.gov
Office address
OCBC CENTRE #27-07, 65 CHULIA STREET, S••••••••, 049513adviserinfo.sec.gov
Business phone
+65 6535-5335adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Mar 31, 2023
Private funds reported
1 (1 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$66.2Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
T•• N••••••••• R•••••••• L••••• T•••• D•••• D••••••• 1•• 2••• (Member Of L••••••••• S•••••••• Associates, Llc), B; J•••• W• L••••••• a•• J••••• S• L•••••••• T••••••• o• t•• J•• L••••••• F••••• T•••• D•••• J••• 1•• 2••• (Member), C; H•••• a• P••••• J•• a•• L••• M• P••••• T••••••• o• t•• P•••• F••••• T•••• U•••• D•••• S•••••••• 7• 1••• (Member Of L••••••••• S•••••••• Associates, Llc), B; M•••••• a• C••••• a•• M••• C• C•••••• A• T••••••• o• t•• C••••• F••••• T•••• D•••• J••• 1•• 2••• (Member), C; L••••••••• V••••••• (Member Of L••••••••• S•••••••• P••• L•••), E
business phone
+65 6535-5335adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
healthcare, biotech, medtech, consumer
Stages
seed, early, multi stage
Geography
boston, europe, global, globally, north carolina, singapore, uk
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
accelerator
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
L••••••••• S••••••••• L•••Fund2016 form d first saleHarvest$66.2M
Mar 31, 2023
3$50.0M
of $50.0M
Jan 27, 2016
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
10 current, 0 departed
H•••• A••••• P••••
Trustee Of The P•••• Family Trust U/D/T D•••• S•••••••• 7, 1994 · since Sep 1, 1994
Board or advisory
J••••• L•••••••
Trustee Of The J&J L••••••• Family Trust D•••• J••• 18, 2004 · since Jun 1, 2004
Board or advisory
K•••••• D••••• N•••••
Trustee Of T•• N••••••••• R•••••••• L••••• T•••• D•••• D••••••• 1•• 2••• · since Dec 1, 2018
Board or advisory
L••• P••••
Trustee Of The P•••• Family Trust U/D/T D•••• S•••••••• 7, 1994 · since Sep 1, 1994
Board or advisory
M••• C•••••••• C•••••
Trustee Of The C••••• Family Trust D•••• J••• 19, 2016 · since Jul 1, 2016
Board or advisory
M•••••• a• C•••••
Trustee Of The C••••• Family Trust D•••• J••• 19, 2016 · since Jul 1, 2016
Board or advisory
T•••• R••••••
Trustee Of T•• N••••••••• R•••••••• L••••• T•••• D•••• D••••••• 1•• 2••• · since Dec 1, 2018
Board or advisory
J••• M• G•••••
Member/Director Of L••••••••• S•••••••• Associates, Llc · since Jan 1, 2016
Principal
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
17 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
  1. Dec 1, 2018
    T•••• R•••••• joined Schedule A of L••••••••• S•••••••• P••• L••• as Trustee Of T•• N••••••••• R•••••••• L••••• T•••• D•••• D••••••• 1•• 2•••
  2. Apr 1, 2018
    T••••• J••• B••••••• joined Schedule A of L••••••••• S•••••••• P••• L••• as Chief Financial Officer
  3. Mar 31, 2017
    L••••••••• S•••••••• P••• L••• first filed Form ADV (ERA, venture capital fund adviser exemption)
Classification history
  1. Sep 12, 2026
    Accelerator (probable, 80%, cls-1)
    name or self-description says accelerator
Evidence
30 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeexempt_reporting_adviserMar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2017-03-31Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2023-03-31Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone+65 6535-5335Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersS••••••••, S••••••••Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office addressOCBC CENTRE #27-07, 65 CHULIA STREET, S••••••••, 049513Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeaccelerator
The Company is a new accelerator that will aim to help launch and support new biotech companies.
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formOther (specify)Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported1Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$66.2MMar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyboston,europe,global,globally,north carolina,singapore,uk
geography words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech,medtech,consumer
sector words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesseed,early,multi_stage
stage words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported1Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://l•••••••••.com/Mar 31, 2023FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleL••••••••• V••••••• – Investing in Medical Breakthroughs
title tag
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)